INS and inherited lipid metabolism disorder: It is also likely that in vivo, abnormal glucose metabolism is not the sole cause of aberrant lipid metabolism within the placenta and that maternal insulin levels and dyslipidaemia may also be an important determinant of placental fatty acid metabolism.